#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Frostbite Ehlers-Danlos syndrome Astrocytoma malignant Trigeminal neuralgia Sjogren's syndrome Corneal neovascularisation Chondrosarcoma metastatic Myelodysplastic syndrome Blastic plasmacytoid dendritic cell neoplasia Henoch-Schonlein purpura nephritis Malignant neoplasm of choroid Peripheral T-cell lymphoma unspecified Isodicentric chromosome 15 syndrome Henoch-Schonlein purpura Type IIa hyperlipidaemia More trials…

    Learn about Rare Diseases

    Toxic epidermal necrolysis – Life with Disease Pleural mesothelioma malignant – Treatment Mucous membrane pemphigoid – Life with Disease Bronchopulmonary dysplasia Hereditary motor and sensory neuropathy – Diagnostics Arterial tortuosity syndrome – Treatment Mucopolysaccharidosis – Life with Disease Rosai-Dorfman syndrome – Diagnostics Erdheim-Chester disease – Treatment Small intestine leiomyosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    RUBIDIUM CHLORIDE Rbd5044 Sodium Db-Oto-3 Verapamil Hydrochloride HLX43 Bupivacaine Hydrochloride Masofaniten Peginterferon Beta-1A VENT-03 SONLICROMANOL HYDROCHLORIDE AUROCELL-TX Namilumab Valemetostat Tosilate Temocillin Sodium Bevacizumab Cft1946 Topiramate Coffee Charcoal Lenvatinib Lenograstim More therapies…

    Learn about Your Condition

    Multiple sclerosis relapse Osteosarcoma metastatic Epstein-Barr virus infection Food allergy Ocular melanoma Metastases to liver Chronic sinusitis Oesophageal achalasia Endometrial cancer stage III Primary biliary cholangitis Fallopian tube cancer Brain abscess Hyperparathyroidism primary Cardiomyopathy Vitamin D deficiency More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Seasonal allergy

  • Study of sublingual immunotherapy with Phleum pratense pollen extract spray in patients with moderate to severe grass pollen allergic rhinitis

    Not recruiting

    4 1
    Investigated Diseases:
    • Conjunctivitis allergic
    • Seasonal allergy
    Investigated Drugs:
    • Phleum Pratense Pollen Extract
    Germany

  • Study of sublingual birch pollen extract (SLI-RX-BET) in different doses for patients with moderate to severe allergic rhinitis caused by birch pollen

    Not recruiting

    4 1
    Investigated Drugs:
    • Betula Pollen Extract
    Germany

  • Study of CLU-RX-BET injection therapy for patients with moderate to severe birch pollen allergies

    Not recruiting

    4 1
    Investigated Diseases:
    • Conjunctivitis allergic
    • Seasonal allergy
    Germany

  • Study on the Effectiveness and Safety of CLU-RX-DPT for Patients with Moderate-to-Severe House Dust Mite Allergy

    Not recruiting

    4 1
    Investigated Drugs:
    • Dermatophagoides Pteronyssinus Allergoid, Glutaraldehyde-Modified
    Germany Spain

  • Study on the Effectiveness and Safety of a Grass and Olive Pollen Allergy Vaccine for Patients with Allergic Rhinitis or Asthma

    Not recruiting

    3 1
    Investigated Drugs:
    • Allergen Extract From Dactylis Glomerata Pollen, Glutaraldehyde-Modified
    • Allergen Extract From Lolium Perenne Pollen, Glutaraldehyde-Modified
    • Allergen Extract From Phleum Pratense Pollen, Glutaraldehyde-Modified
    Spain

  • Study on the Effectiveness and Safety of Allergenic Extract of Olea Europaea Pollen for Patients with Moderate-to-Severe Olive Pollen Allergy

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Conjunctivitis allergic
    • Seasonal allergy
    Investigated Drugs:
    • Allergenic Extract Of Olea Europaea Pollen Polymerized With Glutaraldehyde
    • Alternaria Alternata Extract
    • Ambrosia Artemisiifolia Pollen Extract
    Spain
Previous Page
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!